Alnylam Pharmaceuticals (NASDAQ:ALNY) rallies 3.8% this week, taking five-year gains to 246%
Investing in stocks carries risks of potential loss, but also the opportunity for high returns. Alnylam Pharmaceuticals has shown impressive growth in share price due to strong revenue growth, making it worth considering for investment. Analyzing various factors is crucial for a thorough assessment before investing.